More pushback against copay programs likely on the horizon: Precision’s Ryan Cox and Reta Mourad, PharmD, FNTP discuss why a federal court’s decision striking down a CMS rule that would have narrowed the exclusions from Medicaid best price for manufacturer-provided patient-assistance programs, as well as a recent pharma lawsuit against a maximizer company, could spur more states to take action of their own.

Read the full article here!